A statement released today by Joh. Berenberg Gossler & Co. KG about Gerresheimer (ETR:GXI) ups the target price to 80.00EUR
- Updated: October 12, 2016
Gerresheimer (ETR:GXI) had its target price raised to 80.00EUR by Joh. Berenberg Gossler & Co. KG in a report released 10/12/2016. The new target price indicates a possible upside of 0.13% based on the company's last stock close price.
Previously on 10/11/2016, HSBC reported about Gerresheimer (ETR:GXI) raised the target price from 0.00EUR to 72.00EUR. At the time, this indicated a possible upside of 0.01%.
Yesterday Gerresheimer (ETR:GXI) traded 0.00% even at 70.68EUR. The company’s 50-day moving average is 0.00EUR and its 200-day moving average is 0.00EUR. The last stock close price is up 0.00% from the 200-day moving average, compared to the S&P 500 which has decreased -0.01% over the same time. 0 shares of the stock were exchanged, down from an average trading volume of 0
See Chart Below
Gerresheimer has a 52 week low of 0.00EUR and a 52 week high of 0.00EUR The company’s market cap is currently 0 EUR.
About Gerresheimer (ETR:GXI)
Gerresheimer AG is a Germany-based company that operates in the pharmaceuticals and health care industry. It is structured in three business segments: Plastic and Devices, Primary Packaging Glass and Life Science Research. The Company produces pharmaceutical packaging products, as well as drug-delivery systems made out of glass and plastics or a combination of both. Its product portfolio includes insulin pens, inhalers, pre-fillable syringes, vials, ampoules, bottles and containers for liquid and solid pharmaceuticals with closure and safety systems, plus cosmetic packaging products. The Company operates approximately 40 production facilities in Europe, North America, South America and Asia.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.